Ajinomoto has completed the acquisition of Althea Technologies, a provider of biopharmaceutical development and manufacturing services. All the capital stock of Althea is purchased by Ajinomoto at closing for approximately $175m. Althea ...
Tags: Ajinomoto, Althea Technologies, Medicine